HIV 1 News and Research

RSS

Proxalutamide shows promise as potential COVID-19 treatment

At the outset of the COVID pandemic, men appeared to suffer higher rates of severe illness and death, leading researchers to suspect a link between androgen receptors - which bind to hormones like testosterone--and SARS-CoV-2 viral infection.

18 Aug 2023

A peek at Big Pharma’s playbook that leaves many Americans unable to afford their drugs

America's pharmaceutical giants are suing this summer to block the federal government's first effort at drug price regulation.

18 Aug 2023

Moffitt receives NCI grant to investigate virus-associated tumors among HIV patients in sub-Saharan Africa

The Center for Immunization and Infection Research in Cancer at Moffitt Cancer Center is expanding its viral infection research in Africa. The cancer center has received a $5.5 million, five-year specialized research center grant (U54CA277834) from the National Cancer Institute to investigate virus-associated tumors that disproportionately impact men and women living with HIV in sub-Saharan Africa.

17 Aug 2023

Recreational drug use may worsen outcomes for cardiac intensive care patients

Recreational drug use may be a factor in a significant proportion of admissions to cardiac intensive care, with various substances detected in 1 in 10 such patients, suggest the findings of a multicentre French study published online in the journal Heart.

17 Aug 2023

Doctors hesitate to ask about patients’ immigration status despite new Florida law

Fearful of risking their jobs, jeopardizing state funding for their institutions, and further politicizing health care, Florida hospital leaders have been reluctant to speak out against a new law that requires them to ask about patients' immigration status.

17 Aug 2023

Study evaluates differences in humoral immune response against SARS-CoV-2 in infants versus mothers

Researchers comparatively evaluated humoral immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among infants and their mothers.

16 Aug 2023

Does nutritional support benefit adult pulmonary tuberculosis patients?

Researchers evaluated the impact of nutritional support in Indian adults with microbiologically confirmed pulmonary tuberculosis.

14 Aug 2023

Inflammatory profiles in vaccinated vs. unvaccinated individuals following SARS-CoV-2 infection

A group of researchers determined the impact of vaccination on inflammation levels in individuals infected with SARS-CoV-2.

10 Aug 2023

New pathway for HIV to enter nucleus of healthy cells identified

A study published on August 10, 2023 in the journal Nature Communications has identified a new pathway that human immune deficiency virus (HIV) uses to enter the nucleus of a healthy cell, where it can then replicate and go on to invade other cells.

10 Aug 2023

Have social determinants of health affected COVID-19 vaccine uptake?

Researchers investigated clinically significant predictors of COVID-19 vaccination uptake among individuals with social and medical susceptibility to SARS-CoV-2 infection.

10 Aug 2023

Antimicrobial resistance linked to 569,000 deaths in the Americas in 2019

569,000 deaths were linked to bacterial antimicrobial resistance (AMR) in all 35 countries of the WHO Region of the Americas, according to a new peer-reviewed paper published in The Lancet Regional Health – Americas.

8 Aug 2023

Hepatitis C treatment initiation found to be low among Medicaid recipients

While there are highly effective treatments for the hepatitis C virus (HCV), only 1 in 5 Medicaid enrollees diagnosed with HCV started treatment, according to a retrospective study led by researchers at Weill Cornell Medicine and Cornell University's Ithaca campus.

8 Aug 2023

Genome editing in the spotlight: genetic disorder carriers' views shape the conversation

Study explores perspectives on the applications of somatic genome editing.

8 Aug 2023

Preventive TB treatment for contacts could save lives and money

Administering preventive tuberculosis (TB) treatment to contacts of infected people could significantly cut deaths, and save money, researchers say.

7 Aug 2023

People living with HIV respond well to COVID-19 infection and vaccination

Researchers examine the antibody response to natural infection or COVID-19 vaccination in individuals living with HIV infection.

7 Aug 2023

Penn State researchers develop new method for creating cyclopropanes

Chemical structures called cyclopropanes can increase the potency and fine-tune the properties of many drugs, but traditional methods to create this structure only work with certain molecules and require highly reactive - potentially explosive - ingredients. Now, a team of researchers from Penn State has identified and demonstrated a safe, efficient and practical way to create cyclopropanes on a wide variety of molecules using a previously undescribed chemical process.

4 Aug 2023

Racial disparities in mortality rates persist in the United States

An analysis of 19 causes of death in the United States revealed persistent disparities and a familiar pattern across five racial-ethnic groups and 3,110 counties from 2000 to 2019. That's according to the most comprehensive peer-reviewed research published today in The Lancet.

4 Aug 2023

Genome-wide study finds link between CHD1L gene and HIV control

"We searched for human genetic variation that associates with spontaneous control of HIV and identified a novel region in the genome that is only variable in populations of African ancestries," says Professor Jacques Fellay at EPFL's School of Life Sciences.

2 Aug 2023

Child-friendly HIV drug could improve treatment outcomes

Researchers at the University of Colorado Anschutz Medical Campus have helped confirm the dosing, safety and effectiveness of a drug formulation designed for treating children with human immunodeficiency virus (HIV).

2 Aug 2023

Genetic variant may explain why some people of African ancestry have lower HIV viral loads

An international team of researchers has found a genetic variant that may explain why some people of African ancestry have naturally lower viral loads of HIV, reducing their risk of transmitting the virus and slowing progress of their own illness.

2 Aug 2023

HIV 1 News and Research

Proxalutamide shows promise as potential COVID-19 treatment

A peek at Big Pharma’s playbook that leaves many Americans unable to afford their drugs

Moffitt receives NCI grant to investigate virus-associated tumors among HIV patients in sub-Saharan Africa

Recreational drug use may worsen outcomes for cardiac intensive care patients

Doctors hesitate to ask about patients’ immigration status despite new Florida law

Study evaluates differences in humoral immune response against SARS-CoV-2 in infants versus mothers

Does nutritional support benefit adult pulmonary tuberculosis patients?

Inflammatory profiles in vaccinated vs. unvaccinated individuals following SARS-CoV-2 infection

New pathway for HIV to enter nucleus of healthy cells identified

Have social determinants of health affected COVID-19 vaccine uptake?

Antimicrobial resistance linked to 569,000 deaths in the Americas in 2019

Hepatitis C treatment initiation found to be low among Medicaid recipients

Genome editing in the spotlight: genetic disorder carriers' views shape the conversation

Preventive TB treatment for contacts could save lives and money

People living with HIV respond well to COVID-19 infection and vaccination

Penn State researchers develop new method for creating cyclopropanes

Racial disparities in mortality rates persist in the United States

Genome-wide study finds link between CHD1L gene and HIV control

Child-friendly HIV drug could improve treatment outcomes

Genetic variant may explain why some people of African ancestry have lower HIV viral loads

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News